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Abstract
Background Tissue engineering of skin with near-normal
anatomy is an intriguing novel strategy to attack the still
unsolved problem of how to ideally cover massive full-
thickness skin defects. After successful production of large,
pig cell-derived skin analogues, we now aim at developing
an appropriate large animal model for transplantation
studies.
Materials and methods In four adult Swiss pigs, full-
thickness skin defects, measuring 7.5 9 7.5 cm, were sur-
gically created and then shielded against the surrounding
skin by a new, self-designed silicone chamber. In two
animals each, Integra dermal regeneration templates or
cultured autologous skin analogues, respectively, were
applied onto the wound bed. A sophisticated shock-absorb-
ing dressing was applied for the ensuing 3 weeks. Results
were documented photographically and histologically.
Results All animals survived uneventfully. Integra healed
in perfectly, while the dermo-epidermal skin analogues
showed complete take of the dermal compartment but spots
of missing epidermis. The chamber proved effective in
precluding (‘‘false positive’’) healing from the wound
edges and the special dressing efficiently kept the operation
site intact and clean for the planned 3 weeks.
Conclusion We present a novel and valid pig model
permitting both transplantation of large autologous, labo-
ratory-engineered skin analogues and also keeping the site
of intervention undisturbed for at least three postoperative
weeks. Hence, the model will be used for experiments
testing whether such large skin analogues can restore near-
normal skin, particularly in the long term. If so, clinical
application can be envisioned.
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Introduction
In the preceding companion paper [1] (‘‘Skingineering I’’,
published in this issue) we have provided detailed infor-
mation concerning the notorious clinical problems when
large or massive full-thickness skin defects have to be
covered. Moreover, we have outlined the rationale for tis-
sue engineering of skin with near-normal architecture as
a potential novel strategy to overcome the mentioned
problem.
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As a matter of fact, the successful transplantation of
small human cell-derived skin analogues on athymic rats
[2–4] represents an important step forward with regard to
eventual clinical application of this technique, and it led us
to design a further experimental series where autologous
large scale transplantation of such constructs should be
tested in a large animal model. In the aforementioned
companion paper [1] we report on the engineering of pig
cell-derived skin substitutes suitable for transplantation in a
pig model.
The goal of the present study was to create such a pig
model that allows standardised large-scale transplantation
of laboratory-engineered autologous skin analogues. This
model, if valid, would then be used for additional pre-
clinical experiments looking in detail at various critical
aspects including particularly functional and cosmetic
long-term outcomes of the so reconstituted skin.
Materials and methods
Animals
Adolescent female Swiss pigs (Edelschwein), aged
between 2 and 3 months, weighing between 30 and 35 kg
were housed in a group of 4, received adequate quantities
of pellet food, yoghurt, and they had access to water
ad libitum. They were provided with natural day–night
cycles. For the purpose of acclimatisation, housing began
2 weeks before the start of the experimental phase. Fol-
lowing skin biopsy, they were again housed in a group of
4 for another 3 weeks until the formal operative proce-
dure. In order to minimise the risk of peer-inflicted
damage to the operation site, they were thereafter housed
individually in neighbouring stalls for the ensuing three
postoperative weeks until they were killed (details see
below).
Silicone chamber
In order to prevent any spontaneous healing processes
from the wound edges, a silicone chamber was sutured to
the wound edges after creation of the skin defect. This
device was newly designed (by first author CS) and fab-
ricated (by Carsten Linti, ITV Denkendorf, Germany;
Fig. 1).
The transplantation chamber consists of two parts: the
chamber, and the cover plate. Both parts are made from
silicone rubber using a special cast procedure. The elastic
chamber has hardness (shore A) of 80 after curing and
removal from the mould. The cover plate is casted from a
two-part silicone rubber that cures at room temperature.
The flexible cover has hardness (shore A) of 25.
The moulded silicone rubber parts are biocompatible,
biostable, and heat-resistant (200C) and thus amenable to
standard sterilisation processes, e.g. steam sterilisation.
Anaesthesia and pain management
The study protocol was approved by the local Committee for
Experimental Animal Research (Kantonales Veterina¨ramt
des Kantons Zu¨rich, permission number 172/2009).
Prior to all surgical procedures, the pigs were fasted
overnight to avoid vomiting and aspiration. At first, all
animals were sedated by an intramuscular injection of a
mixture of ketamine 20 mg/kg (Narketan 10 ad us. vet.,
Ve´toquinol AG, Switzerland), azaperone 1.25 mg/kg
(StresnilTM ad us. vet., Biokema SA, Switzerland) and
atropine 0.03 mg/kg (Atropine 0.1%: Kantonsapotheke
Zu¨rich, Switzerland). A venous catheter was placed at the
ear to apply propofol (20 mg i.v.) (Disoprivan 1% Astra
Zeneca, Switzerland) to facilitate intubation. Animals were
then intubated with an endotracheal tube 8 mm in diameter
(Aire CufTM, Veterinary Endotracheal Tube, all Silicone,
Bivona Inc., Indiana, USA) and artificial respiration was
applied. Anaesthesia was maintained with 2.5% isoflurane
(AttaneTM isoflurane ad us. vet., Minrad Inc., New York,
Fig. 1 Silicone chamber. a Silicone chamber designed to prevent
spontaneous healing from the surrounding skin. The area inside the
chamber measures 7 9 7 cm. b Schematic drawing showing the
organisation of the wound area with the implanted silicone chamber:
1 muscle including overlying fascia, 2 skin analogue, 3 soft silver
foam, 4 silicone chamber, 5 pig skin, 6 2 mm thick silicone cover
plate to close the chamber, 7 Fixation sutures
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USA) in oxygen (4.5 l/min). The operation field was
shaved and the skin was disinfected.
Anaesthesia was terminated by leaving the animal on
oxygen alone. When breathing normally, the animal was
extubated. Intraoperative analgesia was provided by bupr-
enorphine, 0.01 mg/kg (Temgesic, Essex Chemie AG,
Switzerland). Post-operative analgesia was provided by a
transdermal fentanyl matrix patch (50 lg/h) (Durogesic
Matrix, Janssen-Cilag AG, Switzerland). Antimicrobial
prophylaxis was intraoperatively provided by augmentin
(600 mg i.v.) (Augmentin, GlaxoSmithKline AG, Swit-
zerland) and continued for 5 days (2 9 625 mg p.o.).
Operative procedures
Biopsy
Animals were anaesthetised as described above, placed in a
left lateral position, and disinfected. A strip-shaped
(1 9 10 cm) full-thickness skin biopsy was harvested from
the right hemiabdomen, and the wound was sutured closed.
The specimen was then processed as detailed in the twin
paper [1].
Creation of full-thickness skin defect, chamber
implantation, and transplantation of skin substitutes
Three weeks post biopsy, animals were again anaesthetised
as described, placed in prone position, shaved, and disin-
fected. A square-shaped, 7.5 9 7.5 cm, full-thickness skin
defect over the midline lumbar area was created. Particular
care was taken to excise a tissue plate including the entire
subcutaneous fat layer so as to ascertain all epithelial ele-
ments that could have contributed to later epithelialization
were removed (Fig. 2a).
The silicone chamber was then implanted and fixed to
the skin edges as outlined above (Fig. 2b; n = 4).
In two animals, the wound was covered with Integra
dermal regeneration template (IDRT) in order to obtain
immediate and reliable wound protection [5] a setting that
allows studying the behaviour and the biologic effects of
the chamber over time. In two other animals, a cultured
skin substitute [1] was transplanted in order to phenome-
nologically test graft take (Fig. 2c). All wound sites were
covered with a soft silver foam dressing. The chamber was
closed with a 2-mm-thick silicone cover plate (Fig. 2d).
With the purpose of protecting the operation sites in an
optimal way against any sort of potential mechanical
trauma over the ensuing 3 weeks, a multilayer shock
absorber device was installed comprising elements atten-
uating direct as well as sheering forces (Fig. 3) and held in
place by a customized garment (Fig. 4).
Postoperative management, euthanasia: harvesting
and processing of samples
All animals were individually housed for 3 weeks post-
operatively with weekly dressing changes and wound site
documentations. Thereafter, they were killed by intrave-
nous administration of pentobarbital (40–60 mg/kg i.v.,
Fig. 2 Surgical procedure of
skin substitute transplantation.
a A full-thickness skin defect of
7.5 9 7.5 cm, located over the
lumbar area is created. b The
silicone chamber is implanted
and secured by fixation sutures.
c The cultured skin substitute is
transplanted onto the full-
thickness wound. d The wound
is covered with soft silver foam
(grey) and a 2-mm-thick
silicone cover plate
(arrowhead)
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Esconarkon, ad us. vet., Streuli Pharma AG, Switzerland).
After chamber removal, all wound sites were completely
excised and processed for histology (H&E staining).
Results
All pigs survived all experimental procedures and the
postoperative phase without any significant complications.
The silicone chambers could be inserted into the wound and
sewed in place according to the outlined specifications in all
animals. Both IDRT and skin analogue placement onto the
chamber-sheltered wound bed could be performed without
any problem. Over the ensuing 3 weeks (formal dressing
changes after 1 and 2 weeks), both the dressings and shock-
absorber devices remained in place and intact. No adverse
events, especially bleeding, infection, or traumatic damage,
were observed. Macroscopically, the chamber did not cause
any particular reaction within the surrounding tissues like,
e.g. a pronounced inflammatory response or excessive gran-
ulation tissue production, nor did it exhibit any obvious signs
of material damage like, e.g. deformation, frailty, altered
consistency, surface erosion, rust, or colour change.
The IDRT implantation yielded a take of 100% after
1 week and the usually encountered peach colour after
3 weeks indicating correct ingrowth and vascularization in
both animals [6]. No signs of infection and no obvious
findings indicating any kind of unfavourable interaction of
surrounding skin and/or IDRT with the chamber were
identified (Fig. 5a, b). Histologically, the Integra demon-
strated the expected and well-documented architecture of a
neodermis 3 weeks post implantation [6, 7] (Fig. 5c).
Cultured dermo-epidermal skin substitutes showed a take
(determined also 1 week after transplantation) of the dermal
part of nearly 100%, whereas the epidermal coverage was
estimated between 50 and 60% (Fig. 6a). Histologically
(3 weeks post transplantation), the dermal compartment
demonstrated the well-known features characterising a
neodermis while the epidermis was well established and
correctly stratified in some areas (Fig. 6b), whereas in other
areas, it was missing.
Discussion
The study reported here provides compelling evidence that
we have established a valid pig model that allows trans-
plantation of large autologous skin analogues and also
warrants the site of operation be kept undisturbed for at
least 3 weeks after transplantation. The following pivotal
profile properties of this large animal model deserve to be
addressed in more detail.
First, the model permits transplantation of sizeable
grafts measuring 7 9 7 cm. This size is suitable for large-
scale transplantation as it equals for instance the usual size
of commercially available cultured epidermal autografts
for clinical use [8]. Also, it has similar dimensions as
conventional split thickness skin grafts applied on human
patients, especially on children [9].
Second, autologous transplantation as performed in this
experiment parallels the future clinical situation where,
obviously, only autologous skin analogue-coverage of
full-thickness skin defects can potentially provide definitive
repair in human patients.
Fig. 3 Multilayered shock absorber device. Schematic drawing
showing the architecture of the device: 1 muscle including overlying
fascia, 2 skin analogue, 3 soft silver foam, 4 silicone chamber, 5 pig
skin, 6 fixation tapes encasing the foam, 7 foam, 8 customized
garment
Fig. 4 Customized garment. a Schematic drawing of the customized
garment for pigs, indicating the essential features: 1 two separate
zippers, 2 neoprene insertion, 3 border of lambskin upholstery, 4
elastic fabric strip. Arrowhead indicates location of shock absorber
device under garment. b Picture showing the ‘‘custom-made’’
garment on a pig
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Third, the silicone chamber insertion was done for sci-
entific reasons alone: we wanted, particularly in view of the
future experiments, to explicitly and reliably shield the area
of interest from any (even partial) false-positive results
through healing from the wound edges. Overall, the chamber
seems to be a valid device in that its handling proved to be
easy, and it granted the wanted strict compartmentalisation
of the operation field from the surrounding skin. Moreover,
there were no macroscopically detectable adverse effects, in
particular impaired healing, coming from the chamber itself.
Of note, IDRT healed in promptly and uneventfully as was to
be expected, while the much more delicately engineered
skin analogues healed with spotty epidermal deficits. The
random pattern epidermal lack, however, speaks against a
chamber-associated problem as then, the non-epithelialized
areas would most likely lay adjacent to the chamber. Yet, the
graft healing observed must not be over-interpreted in any
direction. The goal of this experiment was the establishment
of a large animal/large graft transplantation model, not the
in-depth investigation of results after grafting. The latter
will be looked at specifically in a next series of formal
experiments.
It is noteworthy that our chamber is by far the largest and
first rectangular such device ever published. All other
chambers used for similar purposes were round in shaped
and had a maximum diameter or 4 cm [10–12]. In terms of
an outlook, we figure that the size of this chamber can easily
be enlarged, or, alternatively, two or more adjacent cham-
bers could be jointly used in the same animal if large enough.
Fourth, an obligatory requirement of the model is
maximum graft protection for the first postoperative weeks,
when the graft is most vulnerable, and when the animal is
presumably most annoyed and therefore prone to get rid of
the irritation in any way possible. Therefore, we chose the
back as operation site since the animal cannot reach this
area with mouth or extremities. Also, rubbing is, even
though not entirely impossible, rather challenging. Clearly,
adequate pain management and individual housing, the
combination of a closed-up chamber, and a sophisticated
overlying shock-absorbing dressing proved effective in all
animals alike. This aspect cannot be overemphasised since
all envisioned future experiments rely on long-term
observation (up to 6–12 months), so grafts must definitely
survive the initial phase until, when stable enough, they can
eventually be left without dressing.
Finally, pig skin is the closest relative with regard to
human skin in terms of anatomy and physiology [13, 14].
Therefore, a pig model as the one presented here appears to
be the most appropriate choice for a preclinical setting in
view of future skin analogue transplantations in human
patients.
In conclusion, we devised a practicable new pig model
allowing transplantation of large autologous, laboratory-
engineered skin analogues and that, importantly, allows
Fig. 5 Dermal substitute
integra (IDRT) 3 weeks after
transplantation. a Macroscopic
view of the transplanted IDRT
in place. b Macroscopic view of
an IDRT-derived neodermis,
silicone foil already removed.
c Haematoxylin and Eosin
staining of the excised IDRT
(scale bar 100 lm)
Fig. 6 Laboratory-grown skin
substitute 3 weeks after
transplantation. a Macroscopic
view of the excised skin
substitute. Dotted line indicates
epithelialized area. Arrowheads
indicate locations of previously
taken punch biopsies.
b Haematoxylin and Eosin
staining of the excised skin
substitute with close to normal
epidermis (E) and dermis (D)
(scale bar 50 lm)
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keeping the site of intervention clean and intact for the first
three postoperative weeks. This model appears suitable to
reliably conduct those experiments that will investigate in
detail whether large tissue-engineered skin analogues can
consistently reconstitute near-normal skin also in the long
run. If so, this strategy may eventually be introduced into
clinical practice.
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